Sodium-glucose cotransporter 2 (SGLT2) inhibitors and risk of dementia in people with type 2 diabetes (T2D): A populationbased cohort study

被引：0
|
作者：
Tang, Huilin [1 ]
Shaaban, C. Elizabeth [2 ]
Wu, Yonghui [1 ]
Magoc, Tanja [1 ]
Donahoo, William Troy [1 ]
DeKosky, Steven [1 ]
Bian, Jiang [1 ]
Guo, Serena Jingchuan [1 ]
机构：
[1] Univ Florida, Gainesville, FL USA
[2] Univ Pittsburgh, Pittsburgh, PA USA
来源：
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY | 2023年 / 32卷
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
803
引用
收藏
页码：376 / 376
页数：1
相关论文
共 50 条
  • [21] The potential of sodium glucose cotransporter 2 (SGLT2) inhibitors to reduce cardiovascular risk in patients with type 2 diabetes (T2DM)
    Basile, Jan N.
    JOURNAL OF DIABETES AND ITS COMPLICATIONS, 2013, 27 (03) : 280 - 286
  • [22] Physician experiences with sodium-glucose cotransporter (SGLT2) inhibitors, a new class of medications in type 2 diabetes, and adverse effects
    Patakfalvi, Laura
    Brazeau, Anne-Sophie
    Dasgupta, Kaberi
    PRIMARY HEALTH CARE RESEARCH AND DEVELOPMENT, 2019, 20
  • [23] Sodium-Glucose Cotransporter 2 Inhibitors and Risk of Retinopathy in Patients With Type 2 Diabetes
    Yen, Fu-Shun
    Wei, James Cheng-Chung
    Yu, Teng-Shun
    Hung, Yu-Tung
    Hsu, Chih-Cheng
    Hwu, Chii-Min
    JAMA NETWORK OPEN, 2023, 6 (12) : E2348431
  • [24] Efficacy of Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors in Type 1 Diabetes: A Systematic Review and Meta-analysis
    El Masri, Dana
    Jaber, Linda
    DIABETES, 2017, 66 : LB41 - LB41
  • [25] Sodium-Glucose Cotransporter 2 Inhibitors and Nephrolithiasis Risk in Patients With Type 2 Diabetes
    Paik, Julie M.
    Tesfaye, Helen
    Curhan, Gary C.
    Zakoul, Heidi
    Wexler, Deborah J.
    Patorno, Elisabetta
    JAMA INTERNAL MEDICINE, 2024, 184 (03) : 265 - 274
  • [26] Sodium-glucose cotransporter 2 inhibitors for the management of type 2 diabetes
    Siamashvili, Maka
    Davis, Stephen N.
    EXPERT OPINION ON PHARMACOTHERAPY, 2021, 22 (16) : 2181 - 2198
  • [27] Sodium-glucose cotransporter 2 inhibitors and risk of fractures in postmenopausal women with type 2 diabetes: A nationwide cohort study
    Ko, Hwa Yeon
    Bea, Sungho
    Jeong, Han Eol
    Park, Sohee
    Shin, Ju-Young
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2023, 32 : 81 - 82
  • [28] Erratum to: Sodium-Glucose Cotransporter 2 (SGLT2) Inhibitors and Cardiovascular Disease: A Systematic Review
    Sanjay Kalra
    Rakesh Sahay
    Manash P. Baruah
    Cardiology and Therapy, 2016, 5 (2) : 169 - 169
  • [29] Sodium-Glucose Cotransporter-2 (SGLT2) Inhibitors and Cardiovascular Outcomes: A Review of Literature
    Mani, Sweatha
    Balasubramanian, Abirami
    Veluswami, Keerthana
    Rao, Sudipta
    Aggarwal, Shailesh
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (07)
  • [30] Sodium-Glucose Cotransporter (SGLT2) inhibitors: A new Era in renovascular protection
    Berbari, Adel E.
    INTERNATIONAL JOURNAL CARDIOLOGY HYPERTENSION, 2020, 7
12345